Search Results - "Martí Massó, José F."
-
1
Tau/α‐synuclein ratio and inflammatory proteins in Parkinson's disease: An exploratory study
Published in Movement disorders (01-07-2017)“…ABSTRACT Background: No CSF or plasma biomarker has been validated for diagnosis or progression of PD. Objectives: To assess whether the CSF and plasma levels…”
Get full text
Journal Article -
2
α-Synuclein Levels in Blood Plasma from LRRK2 Mutation Carriers
Published in PloS one (27-12-2012)“…The diagnosis of Parkinson’s disease (PD) remains primarily a clinical issue, based mainly on phenotypic patterns. The identification of biomarkers capable of…”
Get full text
Journal Article -
3
Mutations in the LGI1/Epitempin gene on 10q24 cause autosomal dominant lateral temporal epilepsy
Published in Human molecular genetics (01-05-2002)“…Autosomal dominant lateral temporal epilepsy (EPT; OMIM 600512) is a form of epilepsy characterized by partial seizures, usually preceded by auditory signs…”
Get full text
Journal Article -
4
Prion protein codon 129 polymorphism modifies age at onset of frontotemporal dementia with the C.709-1G>A progranulin mutation
Published in Alzheimer disease and associated disorders (01-01-2011)“…Frontotemporal lobar degeneration because of mutations in the progranulin (PGRN) gene presents a high variability both in the clinical phenotype and age of…”
Get full text
Journal Article -
5
Olfactory deficits and cardiac 123I-MIBG in Parkinson's disease related to the LRRK2 R1441G and G2019S mutations
Published in Movement disorders (01-09-2011)“…It has been proposed that olfactory tests and metaiodobenzylguanidine cardiac scintigraphy may help diagnose idiopathic Parkinson's disease in the premotor…”
Get full text
Journal Article -
6
Response to treatment with corticoids in a case of inflammatory amyloid angiopathy without performing a biopsy
Published in Revista de neurologiá (01-10-2012)“…Inflammatory amyloid angiopathy (IAA) is an infrequent presenting symptom of the recently recognised cerebral amyloid angiopathy and its definitive diagnosis…”
Get full text
Journal Article -
7
Cinnarizine-induced parkinsonism: Ten years later
Published in Movement disorders (01-05-1998)“…A retrospective study was carried out to investigate the evolution of patients diagnosed with cinnarizineinduced parkinsonism (CIP) over the past 15 years. A…”
Get full text
Journal Article -
8
Familial prion diseases in the Basque Country (Spain)
Published in Neuroepidemiology (01-01-2005)“…In 1995, a surveillance system for prion diseases was set up in the Basque Country, an autonomous region in northern Spain (2.1 million inhabitants). In the…”
Get more information
Journal Article -
9
Whole-exome sequencing associates novel CSMD1 gene mutations with familial Parkinson disease
Published in Neurology. Genetics (01-10-2017)“…Despite the enormous advancements made in deciphering the genetic architecture of Parkinson disease (PD), the majority of PD is idiopathic, with single gene…”
Get full text
Journal Article -
10
Αlpha-synuclein levels in blood plasma from LRRK2 mutation carriers
Published in PloS one (2012)“…The diagnosis of Parkinson's disease (PD) remains primarily a clinical issue, based mainly on phenotypic patterns. The identification of biomarkers capable of…”
Get full text
Journal Article -
11
The unexpected co-occurrence of GRN and MAPT p.A152T in Basque families: Clinical and pathological characteristics
Published in PloS one (08-06-2017)“…The co-occurrence of the c.709-1G>A GRN mutation and the p.A152T MAPT variant has been identified in 18 Basque families affected by frontotemporal dementia…”
Get full text
Journal Article -
12
Prevalence of cancer in Parkinson's disease related to R1441G and G2019S mutations in LRRK2
Published in Movement disorders (01-05-2014)“…ABSTRACT An inverse relationship between Parkinson's disease (PD) and cancer has been described. However, the association between cancers and genetic forms of…”
Get full text
Journal Article -
13
Penetrance in Parkinson's disease related to the LRRK2 R1441G mutation in the Basque country (Spain)
Published in Movement disorders (30-10-2010)“…The LRRK2 R1441G mutation was first identified in Basque families and it is responsible for 46% of familial Parkinson's disease (PD) and for 2.5% of sporadic…”
Get full text
Journal Article -
14
Identification of a novel THAP1 mutation at R29 amino-acid residue in sporadic patients with early-onset dystonia
Published in Movement disorders (15-12-2009)Get full text
Journal Article -
15
Synuclein Levels in Blood Plasma from LRRK2 Mutation Carriers
Published in PloS one (27-12-2012)“…The diagnosis of Parkinson's disease (PD) remains primarily a clinical issue, based mainly on phenotypic patterns. The identification of biomarkers capable of…”
Get full text
Journal Article -
16
Familial Parkinson's disease: Clinical and genetic analysis of four Basque families
Published in Annals of neurology (01-03-2005)“…During the last few years several loci have been linked to Mendelian forms of Parkinson's disease (PD). To date, 5 causative genes of 10 identified loci are…”
Get full text
Journal Article -
17
Olfactory deficits and cardiac 123 I‐MIBG in Parkinson's disease related to the LRRK2 R1441G and G2019S mutations
Published in Movement disorders (01-09-2011)“…It has been proposed that olfactory tests and metaiodobenzylguanidine cardiac scintigraphy may help diagnose idiopathic Parkinson's disease in the premotor…”
Get full text
Journal Article -
18
High-dose intravenous immune globulin in the management of severe Guillain-Barre syndrome
Published in The Annals of pharmacotherapy (01-01-1992)“…To evaluate the efficacy of high-dose intravenous gammaglobulin (IGIV) versus plasmapheresis in patients with severe Guillain-Barré syndrome (GBS) and compare…”
Get more information
Journal Article -
19
Rombencefalitis y endocarditis por Listeria monocytogenes : una asociación no descrita
Published in Revista de neurologiá (01-07-2016)Get full text
Journal Article -
20
Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease
Published in JAMA neurology (01-01-2015)“…Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common cause of genetic Parkinson disease (PD) known to date. The clinical features of…”
Get more information
Journal Article